Alzheimer's Disease Programs Initiative - State and Community Grant Program
Funding to support the development and expansion of dementia-capable home and community-based service systems in states and communities. Geographic coverage: Nationwide -- Administration for Community Living, U.S. Department of Health and Human Services (Source: Aging funding opportunities via the Rural Assistance Center)
Source: Aging funding opportunities via the Rural Assistance Center - February 24, 2023 Category: Geriatrics Source Type: funding
Research Coordinating Center on the Exposome and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD): Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-011 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to establish a coordinating center that will serve as a centralized hub for accessing, harmonizing, linking, and sharing environmental contextual data and individual exposure data with NIA/NIH-funded projects in order to foster collaboration and accelerate life course research on the social, behavioral, psychological, and economic exposures that shape Alzheimers disease and related dementias (AD/ADRD) outcomes and inequities. Applications to establish the AD/...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 9, 2023 Category: Research Source Type: funding
Using Multimodal Biomarkers to Differentially Diagnose ADRDs for Clinical Trials (U19 Clinical Trial Optional)
Funding Opportunity RFA-NS-24-001 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to enable multi-site clinical validation of a multimodal set of neuroimaging and biospecimen biomarkers to differentially diagnosis three or more similarly presenting neurodegenerative diseases, including at least one of the Alzheimers Disease and Related Dementias (ADRDs). As part of the program deliverables, investigators will be required to work towards qualifying the candidate biomarkers as therapeutic/drug development tools through the FDAs Biomarker Qualification Program. *Note this FOA has cha...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 9, 2023 Category: Research Source Type: funding
Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-018 from the NIH Guide for Grants and Contracts. This FOA invites applications proposing to establish new, or significantly expand existing, interdisciplinary collaborations involving both experimental and computational researchers to simultaneously address a targeted research question in brain aging and Alzheimer's disease (AD),including Alzheimer's disease related dementias (ADRD). This FOA will use the R21/R33 to provide up to 2 years of R21 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 31, 2023 Category: Research Source Type: funding
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to develop, or renew, an Alzheimer's Disease Research Center (ADRC). The National Institute on Aging (NIA) funds ADRCs at major medical institutions across the United States. NIA-funded ADRCs serve as a national resource for research related to Alzheimers disease (AD) and AD-related dementias (ADRD). Additionally, ADRCs work to translate research advances into improved diagnosis and care, as well as find ways to treat, and possibly prevent, AD/ADRD. L...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 11, 2023 Category: Research Source Type: funding
Notice to Extend the Expiration Date of PAR-20-156 "Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)"
Notice NOT-AG-22-051 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 10, 2023 Category: Research Source Type: funding
Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in TBI-related dementia and/or VCID (U24 - Clinical Trials Not Allowed)
Funding Opportunity RFA-NS-23-002 from the NIH Guide for Grants and Contracts. The purpose of this Alzheimers Disease-Related Dementia (ADRD) initiative is to promote the development and distribution of innovative technologies, methods, protocols, and biomedical materials that enhance combined human neuropathology and neuroimaging research with data aimed at understanding the underlying pathophysiology of in vivo imaging results typically associated with vascular contributions to cognitive impairment and dementia (VCID) in TBI-related dementia and other ADRD diagnoses. Resources developed under this FOA must follow open...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 6, 2023 Category: Research Source Type: funding
Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-024 from the NIH Guide for Grants and Contracts. This RFA supports a national survey of professional dementia care providers and link consented survey respondents (providers and institutional representative) that consent to administrative data (e.g., electronic health records, claims, payroll, other institutional and state level data). This new resource anticipates the integration from administrative sources with the provider survey to expand research on the dementia care workforce, supply of skilled labor, and provide deeper insight into how professional care providers and institutions pro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 23, 2022 Category: Research Source Type: funding
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
Funding Opportunity PAR-23-083 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods. (Sour...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 23, 2022 Category: Research Source Type: funding
Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-081 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods. (Source: NIH Fundi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 23, 2022 Category: Research Source Type: funding
Notice of Need to Expire and Reissue RFA-AT-23-008 Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain/Alzheimers Disease/AD Related Dementias (U24 Clinical Trial Optional) to Correct Review Criteria
Notice NOT-AT-23-006 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 16, 2022 Category: Research Source Type: funding
Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
Funding Opportunity RFA-AT-23-009 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support a collection of research networks that promote multidisciplinary mechanistic studies of music-based interventions (MBIs) for pain or Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). These networks are expected to develop compelling research frameworks that will effectively guide future clinical studieson MBIs in these health conditions; adopt consistent terminology and taxonomy; support interdisciplinary collaborations andinitiate pilot projects to test novel mechanistic hypotheses; ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 16, 2022 Category: Research Source Type: funding
Notice of Need to Expire and Reissue RFA-AT-23-006 Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain/Alzheimers Disease/AD Related Dementias (U24 Clinical Trial Optional) to Correct Review Criteria
Notice NOT-AT-23-005 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 8, 2022 Category: Research Source Type: funding
Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
Funding Opportunity RFA-AT-23-008 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support a collection of research networks that promote multidisciplinary mechanistic studies of music-based interventions (MBIs) for pain or Alzheimers disease and Alzheimers disease related dementias (AD/ADRD). These networks are expected to develop compelling research frameworks that will guide future clinical research on MBIs in these health conditions effectively, adopt consistent terminology and taxonomy, support interdisciplinary collaborations, initiate pilot projects testing novel mechanistic hypotheses, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 8, 2022 Category: Research Source Type: funding
Notice of NINDS Specific Interest in AD/ADRD for PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)"
Notice NOT-NS-23-050 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 1, 2022 Category: Research Source Type: funding
